Presenting a significant number of abstracts at a prestigious conference like the American Thoracic Society International Conference is a strong indicator of Insmed's robust research and development activities in the respiratory sector. This could positively influence investor perception, potentially leading to an increase in stock price in the short term as it highlights the company's commitment to advancing respiratory health and its active role in the scientific community.